Intercept Pharmaceuticals Inc (NASDAQ:ICPT) - Share price


Stock Report

Intercept Pharmaceuticals Inc ICPT

Last Price
$60.90

Day Change
-2.08|-3.30%

As of 23/08/2019
19:41:11 EDT | USD
Minimum 15 Minutes Delay.

Last Close62.98
Day Range60.44 - 64.56
Mkt Cap1.99Bil
52-Wk Range58.21 - 133.74
Yield %-
ISINUS45845P1084
Volume532,257
P/E-5.86
P/S8.38
P/CF-7.84

Share Price

Financials
201620172018
More ...
Income Statement
Revenue24.95130.96179.80
Operating Income-402.54-335.61-285.49
Net Income-412.83-360.37-309.24
Basic EPS-16.74-14.38-10.86
Avg. Diluted Shares Outstanding252528
Balance Sheet
Current Assets707.87448.31482.43
Non Current Assets31.3936.0426.74
Total Assets739.25484.35509.17
Current Liabilities78.51104.03114.21
Total Liabilities424.32467.96490.04
Total Equity314.9316.3919.13
Cash Flow
Operating Cash Flow-342.44-265.40-240.71
Capital Expenditure-5.08-10.39-0.17
Free Cash Flow-347.52-275.79-240.88

In millions, except "Basic EPS". Currency is USD.

Company Profile

Intercept Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the development and commercialization of novel therapeutics to treat non-viral, progressive liver diseases with high unmet medical need.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Growth

Fiscal Year Ends

December

Employees

483
Key Stats
More ...
Price/Earning TTM-6.06
Price/Book11.75
Price/Sales TTM9.50
Rev Growth (3 year avg)301.31
EPS Growth (3 year avg)-
Operating Margin % TTM-158.78
Net Margin % TTM-171.99
ROE TTM-1,741.42
Debt/Equity19.41
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.